Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Pediatric Arm of DZL All Age Asthma Cohort

The All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL), Pediatric Arm

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Despite its common occurrence, still little is known about pathomechanisms determining different wheeze and asthma trajectories and phenotypes in children, and those beginning in adulthood. Therefore, deciphering underlying determinants for different childhood and adult asthma phenotypes is urgently needed to develop personalized treatment approaches targeting distinct underlying mechanisms. Thereby, secondary prevention early in the disease process can also be achieved. The decoding of such mechanisms and their translation to the individual patient is the aim of the Disease Area Asthma Allergy of the 'German Centre for Lung Research' (DZL).

Who May Be Eligible (Plain English)

Who May Qualify: - willing to sign a consent form by parents (and by children if age \> 8 years) - age 6 months to 18 years - term delivery (≥ 37 weeks) - active/passive understanding of German - age 6 months - \< 6 years: preschool wheeze (more than two episodes of wheeze during 12 months prior to inclusion) - age at least 6 years: doctor diagnosed asthma (according to current guidelines) Who Should NOT Join This Trial: - known inborn or perinatal pulmonary disease - airway malformation - oxygen therapy after birth with a duration of more than 24 hours - ventilator support or mechanical ventilation after birth - diagnoses of cystic fibrosis; primary ciliary dyskinesia - heart failure diagnosed after birth affecting pulmonary circulation - major respiratory diseases such as e.g. interstitial lung disease - any current non-atopic comorbidity - fever of at least 38.5°C during the last two weeks prior to the planned first visit Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * informed consent by parents (and by children if age \> 8 years) * age 6 months to 18 years * term delivery (≥ 37 weeks) * active/passive understanding of German * age 6 months - \< 6 years: preschool wheeze (more than two episodes of wheeze during 12 months prior to inclusion) * age at least 6 years: doctor diagnosed asthma (according to current guidelines) Exclusion Criteria: * known inborn or perinatal pulmonary disease * airway malformation * oxygen therapy after birth with a duration of more than 24 hours * ventilator support or mechanical ventilation after birth * diagnoses of cystic fibrosis; primary ciliary dyskinesia * heart failure diagnosed after birth affecting pulmonary circulation * major respiratory diseases such as e.g. interstitial lung disease * any current non-atopic comorbidity * fever of at least 38.5°C during the last two weeks prior to the planned first visit

Locations (5)

University Children's Hospital Cologne, Department of Paediatric Allergology and Pneumology
Cologne, Germany
Medizinische Hochschule Hannover, Biomedical Research in Endstage and Obstructive Lung Disease
Hanover, Germany
Universitaetsklinikum Schleswig-Holstein, Klinik für Kinder- und Jugendmedizin, Airway Research Center North
Lübeck, Germany
Klinik für Kinder- und Jugendmedizin, Universitaetsklinikum Giessen und Marburg GmbH, Universities of Giessen and Marburg Lung Center
Marburg, Germany
Klinikum der Universitaet Muenchen, Comprehensive Pulmonary Center Munich
Munich, Germany